Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-028069
Filing Date
2026-08-14
Accepted
2026-08-14 17:30:20
Documents
95
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vbio20260630c_10q.htm   iXBRL 10-Q 2085907
2 EXHIBIT 31.1 ex_976048.htm EX-31.1 13508
3 EXHIBIT 31.2 ex_976049.htm EX-31.2 13479
4 EXHIBIT 32.1 ex_976050.htm EX-32.1 7886
10 logo2.jpg GRAPHIC 6964
  Complete submission text file 0001437749-26-028069.txt   11406054

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vbio-20260630.xsd EX-101.SCH 101602
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vbio-20260630_cal.xml EX-101.CAL 57210
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vbio-20260630_def.xml EX-101.DEF 671234
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vbio-20260630_lab.xml EX-101.LAB 571058
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vbio-20260630_pre.xml EX-101.PRE 717903
99 EXTRACTED XBRL INSTANCE DOCUMENT vbio20260630c_10q_htm.xml XML 2015732
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41052 | Film No.: 261283930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)